(Q36702972)

English

Population pharmacokinetics of rifampin in pulmonary tuberculosis patients, including a semimechanistic model to describe variable absorption

scientific article published on 7 April 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391026%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Population pharmacokinetics of rifampin in pulmonary tuberculosis patients, including a semimechanistic model to describe variable absorption (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391026%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

0 references

1 reference

based on heuristic

inferred from title

pulmonary tuberculosis

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

Justin J Wilkins

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391026%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Helen McIlleron

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391026%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Ulrika S H Simonsson

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391026%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Mats O Karlsson

3

object named as

Mats O Karlsson

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391026%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Radojka M Savic

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391026%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Grant Langdon

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391026%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Goonaseelan Pillai

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391026%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Peter J Smith

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391026%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

language of work or name

0 references

publication date

7 April 2008

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391026%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391026%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

52

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391026%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391026%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

2138-2148

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391026%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

30 September 2017

Pharmacokinetics and tolerability of a higher rifampin dose versus the standard dose in pulmonary tuberculosis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

30 September 2017

Determinants of rifampin, isoniazid, pyrazinamide, and ethambutol pharmacokinetics in a cohort of tuberculosis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

30 September 2017

Serum concentrations of antimycobacterial drugs in patients with pulmonary tuberculosis in Botswana

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

30 September 2017

PsN-Toolkit--a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

30 September 2017

Decreased bioavailability of rifampin and other antituberculosis drugs in patients with advanced human immunodeficiency virus disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

30 September 2017

Perl-speaks-NONMEM (PsN)--a Perl module for NONMEM related programming

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

30 September 2017

Biopharmaceutic and pharmacokinetic aspects of variable bioavailability of rifampicin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

30 September 2017

Population pharmacokinetic modeling of oral cyclosporin using NONMEM: comparison of absorption pharmacokinetic models and design of a Bayesian estimator

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

30 September 2017

Pharmacokinetics-pharmacodynamics of rifampin in an aerosol infection model of tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

30 September 2017

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

30 September 2017

Low plasma concentrations of rifampicin in tuberculosis patients in Indonesia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

30 September 2017

Role of individual drugs in the chemotherapy of tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

30 September 2017

A mechanism-based pharmacokinetic-enzyme model for cyclophosphamide autoinduction in breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

30 September 2017

Population pharmacokinetic modeling of isoniazid, rifampin, and pyrazinamide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

30 September 2017

Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

30 September 2017

Study of the effect of concomitant food on the bioavailability of rifampicin, isoniazid and pyrazinamide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

30 September 2017

Rifampicin, a general review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

30 September 2017

Tuberculosis in the Western Cape health region of South Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

30 September 2017

The Garrod Lecture. Understanding the chemotherapy of tuberculosis--current problems

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

30 September 2017

Clinical Pharmacokinetics of Rifampicin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

30 September 2017

U.S. Public Health Service Cooperative trial of three rifampin-isoniazid regimens in treatment of pulmonary tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

30 September 2017

Concentration-dependent Mycobacterium tuberculosis killing and prevention of resistance by rifampin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

28 June 2018

Bioavailability of rifampicin in a separate formulation and fixed dose combination with isoniazid NIH: a case for a fixed dose combination (FDC) for the treatment of tuberculosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

28 June 2018

Pharmacokinetics of antimycobacterial drugs in patients with tuberculosis, AIDS, and diarrhea

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

28 June 2018

A novel extravascular input function for the assessment of drug absorption in bioavailability studies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

28 June 2018

Third-generation model for corticosteroid pharmacodynamics: roles of glucocorticoid receptor mRNA and tyrosine aminotransferase mRNA in rat liver.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

28 June 2018

The importance of modeling interoccasion variability in population pharmacokinetic analyses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

28 June 2018

Building population pharmacokineticpharmacodynamic models. I. Models for covariate effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

28 June 2018

Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

5 September 2018

Pharmacokinetics of desmopressin administrated as an oral lyophilisate dosage form in children with primary nocturnal enuresis and healthy adults.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

5 September 2018

NONMEMory: a run management tool for NONMEM.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

5 September 2018

Malabsorption of rifampin and isoniazid in HIV-infected patients with and without tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

5 September 2018

Patients' beliefs: do they affect tuberculosis control? A study in a rural district of South Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

5 September 2018

Widespread distribution of a single drug rifampicin formulation of inferior bioavailability in South Africa.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

5 September 2018

Application of a gamma model of absorption to oral cyclosporin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

5 September 2018

Activity of rifapentine and its metabolite 25-O-desacetylrifapentine compared with rifampicin and rifabutin against Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis and M. bovis BCG.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

5 September 2018

Determination of rifampicin, isoniazid and pyrazinamide by high performance liquid chromatography after their simultaneous extraction from plasma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

5 September 2018

Recent bioequivalence studies on fixed-dose combination anti-tuberculosis drug formulations available on the global market.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

5 September 2018

Does AIDS impair the absorption of antituberculosis agents?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

5 September 2018

Use of parallel Erlang density functions to analyze first-pass pulmonary uptake of multiple indicators in dogs.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

5 September 2018

Use of salivary caffeine tests to assess the inducer effect of a drug on hepatic metabolism.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

5 September 2018

Drug malabsorption and resistant tuberculosis in HIV-infected patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

5 September 2018

Use of gamma distributed residence times in pharmacokinetics.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2415769

5 September 2018

Two three-month treatment regimens for pulmonary tuberculosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18391026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicompartmental analysis of serum, urine and bile concentrations of rifampicin and desacetyl-rifampicin in subjects treated for one week

1 reference

https://pubmed.ncbi.nlm.nih.gov/18391026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of oral and intravenous rifampicin during chronic administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/18391026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of the enzyme induction by rifampicin on its presystemic metabolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/18391026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Models of hepatic elimination: Comparison of stochastic models to describe residence time distributions and to predict the influence of drug distribution, enzyme heterogeneity, and systemic recycling on hepatic elimination

1 reference

https://pubmed.ncbi.nlm.nih.gov/18391026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of rifampicin metabolism during treatment of tuberculous patients with daily and fully intermittent regimens containing the drug

1 reference

https://pubmed.ncbi.nlm.nih.gov/18391026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Implication of biopharmaceutics and pharmacokinetics of rifampicin in variable bioavailability from solid oral dosage forms

1 reference

https://pubmed.ncbi.nlm.nih.gov/18391026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

AIDS and TB drug absorption

1 reference

https://pubmed.ncbi.nlm.nih.gov/18391026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Utility of rifampin blood levels in the treatment and follow-up of active pulmonary tuberculosis in patients who were slow to respond to routine directly observed therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18391026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

What is the 'right' dose of rifampin?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18391026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro evaluation of food effect on the bioavailability of rifampicin from antituberculosis fixed dose combination formulations

1 reference

https://pubmed.ncbi.nlm.nih.gov/18391026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Kinetic studies on rifampicin. I. Serum concentration analysis in subjects treated with different oral doses over a period of two weeks

1 reference

https://pubmed.ncbi.nlm.nih.gov/18391026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Binding of rifampicin by human plasma proteins.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18391026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Models for describing absorption rate and estimating extent of bioavailability: application to cefetamet pivoxil

1 reference

https://pubmed.ncbi.nlm.nih.gov/18391026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced plasma concentrations of antituberculosis drugs in patients with HIV infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/18391026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transit compartments versus gamma distribution function to model signal transduction processes in pharmacodynamics

1 reference

https://pubmed.ncbi.nlm.nih.gov/18391026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of presystemic factors on the oral bioavailability of rifampicin following multiple dosing

1 reference

https://pubmed.ncbi.nlm.nih.gov/18391026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Xpose--an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM

1 reference

https://pubmed.ncbi.nlm.nih.gov/18391026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The clinical pharmacokinetics of rifampin and ethambutol in HIV-infected persons with tuberculosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18391026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Statistical evaluation of physiological variability of rifampicin in fixed dose combinations

1 reference

https://pubmed.ncbi.nlm.nih.gov/18391026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative bioequivalence study of rifampicin and isoniazid combinations in healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/18391026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.00461-07

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391026%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391026%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391026%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36702972&oldid=2143457463"